ATE415975T1 - Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis - Google Patents
Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosisInfo
- Publication number
- ATE415975T1 ATE415975T1 AT02733745T AT02733745T ATE415975T1 AT E415975 T1 ATE415975 T1 AT E415975T1 AT 02733745 T AT02733745 T AT 02733745T AT 02733745 T AT02733745 T AT 02733745T AT E415975 T1 ATE415975 T1 AT E415975T1
- Authority
- AT
- Austria
- Prior art keywords
- negatively charged
- restenosis
- phosphorus
- compound
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0101854A SE0101854L (sv) | 2001-05-28 | 2001-05-28 | Användning av en förening med en negativt laddad region av grupper för behandling av restenos. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE415975T1 true ATE415975T1 (de) | 2008-12-15 |
Family
ID=20284248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02733745T ATE415975T1 (de) | 2001-05-28 | 2002-05-28 | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040235799A1 (de) |
EP (1) | EP1390045B1 (de) |
JP (1) | JP2004532872A (de) |
AT (1) | ATE415975T1 (de) |
DE (1) | DE60230134D1 (de) |
DK (1) | DK1390045T3 (de) |
ES (1) | ES2316568T3 (de) |
SE (1) | SE0101854L (de) |
WO (1) | WO2002096436A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20021570A0 (fi) * | 2002-09-03 | 2002-09-03 | Gallen Kallela Siren Janne | Päällystetyn kirurgisen stentin paranneltu rakenne |
US10159297B2 (en) * | 2013-05-21 | 2018-12-25 | Bradford C. Jamison | Patterned plexus of filaments, method of producing and articles containing patterned filaments |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
US5389620A (en) * | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
IT1275935B1 (it) * | 1995-03-17 | 1997-10-24 | Chiesi Farma Spa | Derivato di aminotetralina per la terapia di malattie cardiovascolari |
US6846839B1 (en) * | 1995-06-07 | 2005-01-25 | Sugen, Inc. | Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis |
CA2166155C (en) * | 1995-12-27 | 2008-02-05 | Eva Anne Turley | Agents binding to hyaluronic acid binding domains and the use thereof |
US20040063790A1 (en) * | 1996-05-31 | 2004-04-01 | The Scripps Research Institute | Methods for inhibition of angiogenesis |
AUPO888497A0 (en) * | 1997-09-01 | 1997-09-25 | Australian National University, The | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
US6896659B2 (en) * | 1998-02-06 | 2005-05-24 | Point Biomedical Corporation | Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
US6685938B1 (en) * | 1998-05-29 | 2004-02-03 | The Scripps Research Institute | Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases |
US6028061A (en) * | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
AU6409499A (en) * | 1998-10-01 | 2000-04-17 | Children's Medical Center Corporation | Method of treatment of cardiovascular injuries |
US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
US7019108B2 (en) * | 2001-06-01 | 2006-03-28 | University Of Southern California | Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
WO2004096832A2 (en) * | 2003-04-29 | 2004-11-11 | Children's Medical Center Corporation | Novel antiangiogenic peptides |
JP3958309B2 (ja) * | 2004-08-23 | 2007-08-15 | 株式会社名機製作所 | 射出成形機 |
-
2001
- 2001-05-28 SE SE0101854A patent/SE0101854L/ not_active Application Discontinuation
-
2002
- 2002-05-28 WO PCT/SE2002/001016 patent/WO2002096436A1/en active Application Filing
- 2002-05-28 DE DE60230134T patent/DE60230134D1/de not_active Expired - Lifetime
- 2002-05-28 JP JP2002592945A patent/JP2004532872A/ja active Pending
- 2002-05-28 DK DK02733745T patent/DK1390045T3/da active
- 2002-05-28 US US10/478,962 patent/US20040235799A1/en not_active Abandoned
- 2002-05-28 EP EP02733745A patent/EP1390045B1/de not_active Expired - Lifetime
- 2002-05-28 ES ES02733745T patent/ES2316568T3/es not_active Expired - Lifetime
- 2002-05-28 AT AT02733745T patent/ATE415975T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2004532872A (ja) | 2004-10-28 |
DE60230134D1 (de) | 2009-01-15 |
DK1390045T3 (da) | 2009-02-23 |
SE0101854L (sv) | 2002-11-29 |
US20040235799A1 (en) | 2004-11-25 |
ES2316568T3 (es) | 2009-04-16 |
EP1390045A1 (de) | 2004-02-25 |
WO2002096436A1 (en) | 2002-12-05 |
EP1390045B1 (de) | 2008-12-03 |
SE0101854D0 (sv) | 2001-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04065A1 (en) | Treatment of acute myeloid leukemia with indolinone compounds | |
PT1204322E (pt) | Fungicidas | |
DE69100364D1 (de) | Verwendung von N-Myristoyl-(S)-Phenylalanin zur Herstellung eines Medikaments zur Behandlung von Krankheiten mittels Hemmung der Myristoylierung. | |
RU94031102A (ru) | Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний | |
ATE210440T1 (de) | Behandlung von tumoren mit verbindungen mit einer rxr-retinoid agonistische wirkung | |
DK0840732T3 (da) | Substituerede benzolactamforbindelser som substans P-antagonister | |
ES2186874T3 (es) | Analogos de m-amidinofenilo como inhibidores del factor xa. | |
UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
DE69427344T2 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
IT1319202B1 (it) | Farmaci per le malattie a base infiammatoria. | |
CY1113959T1 (el) | Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης | |
DE60105025D1 (de) | Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie | |
DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
PT1390371E (pt) | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores | |
DK1001761T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser | |
HN2002000110A (es) | Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple. | |
DE60111228D1 (de) | Heteropolycyclische inhibitoren | |
ATE415975T1 (de) | Verwendung einer verbindung mit einer negativ geladenen domäne von phosphor-enthaltenden radikalen für die behandlung von restenosis | |
ATE346844T1 (de) | Verwendung von 2-amino-2h-chinazolin-derivaten zur herstellung von therapeutischen mitteln | |
NO20032406L (no) | Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens | |
ATE549026T1 (de) | Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren | |
DE50014850D1 (de) | Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie | |
SE9602463D0 (sv) | The use of growth factor modulating compounds | |
RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS | |
ATE146964T1 (de) | Behandlung von katarakt mit prostacyclinverbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |